MedTrace Logo

STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease

NCT04848077 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 452

Last updated 2025-04-20

No results posted yet for this study

Summary

The aim of this study is to investigate whether a smartphone app can increase physical activity in patients with Parkinson's Disease in daily life for a long period of time (12 months).

Conditions

Interventions

BEHAVIORAL

Step count increase with the use of a motivational smartphone application

All participants will be given access to an application installed on the participants' own smartphone: the STEPWISE app. The STEPWISE app will encourage participants to increase their long-term physical activity (1 year). Different treatment arms will receive different physical activity goals. Participants will get feedback and support via the smartphone app, that stimulates them to reach their individual physical activity goal (i.e. target percentage increase in stepcount).

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • Hogeschool van Arnhem en Nijmegen (HAN)

    collaborator UNKNOWN

  • Canisius-Wilhelmina Hospital

    collaborator OTHER

  • IJsfontein Health BV

    collaborator UNKNOWN

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Bastiaan Bloem, Prof. Dr. · Radboudumc Department of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04848077 on ClinicalTrials.gov